The pharma’s lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 ...
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...
(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of ...
The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...
UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...
GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...
6don MSN
London: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its ...
Scripps News on MSN6d
British drugmaker sues Moderna for patent infringement related to mRNA vaccinesA British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
GlobalData on MSN4d
mRNA licensing agreements surge 800% amid GSK lawsuitsAn 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...
Axios on MSN6d
GSK sues Moderna over mRNA vaccine technologyGlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...
British drugmaker GlaxoSmithKline sued Moderna in US federal court in Delaware on Tuesday (Oct 15), accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback